Latest filingAug 29, 2026Most recent Form 4
BIVI
BIOVIE INC.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$4.91M4 buys
Total selling$00 sells
Net open-market+$4.91M4 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period4transactions
- P · Open-market buys · dominant4 · 100%
Activity by reported role
A joint filing can contribute to multiple roles5transactions
- Chief executive officer · dominant1 · 20%
- Chief financial officer1 · 20%
- CMO1 · 20%
- Director1 · 20%
- PRES1 · 20%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (4)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeDo Cuong VCommon Stock · Direct
16,117Aug 27, 2026
Kim Joanne WendyCommon Stock · Direct
3,441Aug 28, 2026
Chappell Amy SuzonCommon Stock · Direct
727Aug 28, 2026
Palumbo Joseph MCommon Stock · Direct
6,036Aug 28, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- DV+$31.6k
- PM+$10.5k
- KW+$5.5k
- CS+$1.6k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
BIVI transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIVI | Palumbo Joseph M | CMO | buy | 4.84k | $1.04M | P | — | 08/29 | 08/28 | |
| BIVI | Chappell Amy Suzon | DIR | buy | 727 | $157k | P | — | 08/29 | 08/28 | |
| BIVI | KIM JOANNE WENDY | CFO | buy | 2.50k | $545k | P | — | 08/29 | 08/28 | |
| BIVI | DO CUONG V | PRESCEO | buy | 15.2k | $3.16M | P | — | 08/29 | 08/27 |
BIOVIE INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at BIOVIE INC.?
Palumbo Joseph M, Chappell Amy Suzon, KIM JOANNE WENDY, DO CUONG V.
When was the latest reported open-market purchase?
Palumbo Joseph M reported a buy on Aug 28, 2026 valued at $1.04M. Read the SEC filing.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
Net open-market buying in the selected period was $49,118.00. This describes filed transactions, not a bullish rating.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.